Advertisement
Singapore markets open in 1 hour 17 minutes
  • Straits Times Index

    3,415.51
    +47.61 (+1.41%)
     
  • S&P 500

    5,537.02
    +28.01 (+0.51%)
     
  • Dow

    39,308.00
    -23.90 (-0.06%)
     
  • Nasdaq

    18,188.30
    +159.54 (+0.88%)
     
  • Bitcoin USD

    60,220.72
    -1,782.39 (-2.87%)
     
  • CMC Crypto 200

    1,262.17
    -72.74 (-5.45%)
     
  • FTSE 100

    8,171.12
    +49.92 (+0.61%)
     
  • Gold

    2,369.40
    0.00 (0.00%)
     
  • Crude Oil

    83.88
    0.00 (0.00%)
     
  • 10-Yr Bond

    4.3550
    -0.0810 (-1.83%)
     
  • Nikkei

    40,580.76
    +506.06 (+1.26%)
     
  • Hang Seng

    17,978.57
    +209.47 (+1.18%)
     
  • FTSE Bursa Malaysia

    1,615.32
    +17.36 (+1.09%)
     
  • Jakarta Composite Index

    7,196.75
    -7,125.14 (-49.75%)
     
  • PSE Index

    6,450.03
    +91.07 (+1.43%)
     

Top Undervalued Small Caps With Insider Actions In Australia July 2024

Amidst a fluctuating Australian market where the ASX200 has seen a slight decline and sectors like IT have struggled significantly, small-cap stocks continue to present unique opportunities. Particularly, certain undervalued small caps are drawing attention with insider actions suggesting potential unrecognized value in this turbulent economic landscape. In such conditions, discerning investors might look for stocks that not only show promising fundamentals but also exhibit positive insider engagements, hinting at confidence from those who know the company best.

Top 10 Undervalued Small Caps With Insider Buying In Australia

Name

PE

PS

Discount to Fair Value

Value Rating

Corporate Travel Management

17.5x

2.7x

47.31%

★★★★★★

Nick Scali

13.7x

2.5x

45.54%

★★★★★★

Healius

NA

0.6x

43.37%

★★★★★☆

Codan

28.6x

4.2x

27.32%

★★★★☆☆

Dicker Data

20.8x

0.8x

3.61%

★★★★☆☆

Eagers Automotive

9.6x

0.3x

33.24%

★★★★☆☆

Tabcorp Holdings

NA

0.7x

19.38%

★★★★☆☆

RAM Essential Services Property Fund

NA

5.8x

40.26%

★★★★☆☆

Smartgroup

17.5x

4.3x

49.61%

★★★☆☆☆

Coventry Group

295.6x

0.4x

-21.34%

★★★☆☆☆

Click here to see the full list of 27 stocks from our Undervalued ASX Small Caps With Insider Buying screener.

ADVERTISEMENT

Let's review some notable picks from our screened stocks.

Codan

Simply Wall St Value Rating: ★★★★☆☆

Overview: Codan is a diversified technology company specializing in communications and metal detection, with a market capitalization of approximately A$1.37 billion.

Operations: Communications and Metal Detection are the primary revenue contributors, generating A$291.50 million and A$212.20 million respectively. The company's gross profit margin has shown a trend of fluctuation, with recent figures around 54.42% for the latest reported period.

PE: 28.6x

Codan, a notable player in the Australian market, recently saw insider confidence demonstrated through share purchases, signaling strong belief in the company's prospects. With earnings expected to grow by 16% annually, this reflects positively on its financial trajectory. Despite relying solely on external borrowing—a riskier funding method—these strategic moves suggest a robust foundation for future growth. This blend of insider activity and solid growth forecasts paints Codan as an appealing prospect for those eyeing potential in lesser-known entities.

ASX:CDA Share price vs Value as at Jul 2024
ASX:CDA Share price vs Value as at Jul 2024

Lifestyle Communities

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Lifestyle Communities is a company engaged in property development and management, with a market capitalization of approximately A$1.5 billion.

Operations: In recent financial data, the company reported a gross profit margin of 21.02% and a net income margin of 32.38%. This performance is derived from its primary operation in property development and management, which generated A$239.11 million in revenue.

PE: 19.6x

Lifestyle Communities, a notable player in the Australian market, recently showcased at the Macquarie Australia Conference. With earnings expected to climb by 22% annually, this reflects strong future prospects. Despite relying on higher-risk funding with no customer deposits, they maintain a good financial stance with significant non-cash earnings. Notably, insiders have recently demonstrated their confidence through share purchases, underscoring a belief in the company’s potential growth and current market positioning as undervalued.

ASX:LIC Ownership Breakdown as at Jul 2024
ASX:LIC Ownership Breakdown as at Jul 2024

Neuren Pharmaceuticals

Simply Wall St Value Rating: ★★★★★★

Overview: Neuren Pharmaceuticals is a company focused on the development of pharmaceutical products, with a market capitalization of approximately A$231.94 million.

Operations: Pharmaceutical Products generated A$231.94 million in revenue, with a gross profit margin of 88.47%. The company's operating expenses were A$5.95 million.

PE: 16.4x

Neuren Pharmaceuticals, a lesser-known entity in the Australian market, recently showcased promising Phase 2 clinical trial results for NNZ-2591, targeting Pitt Hopkins syndrome—a condition with no approved treatments. This development could significantly enhance its market position. With revenue projected to increase by over 10% annually, and backed by insider confidence demonstrated through recent share purchases, Neuren's strategic moves suggest a potential upward trajectory in its valuation amidst small-cap peers.

ASX:NEU Share price vs Value as at Jul 2024
ASX:NEU Share price vs Value as at Jul 2024

Make It Happen

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:CDA ASX:LIC and ASX:NEU.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com